{"id":"W2148301853","doi":"10.1136/ard.59.suppl_1.i46","title":"Etanercept (Enbrel): update on therapeutic use","year":2000,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"ca_institutions":"Research & Development Corporation","funders":"","keywords":"Etanercept; Medicine; Methotrexate; Rheumatoid arthritis; Placebo; Adverse effect; Internal medicine; Psoriatic arthritis; Arthritis; Juvenile rheumatoid arthritis; Surgery; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002389629,0.0004887052,0.002264021,0.000241635,0.0001293272,0.00005777357,0.0006762362,0.0001974343,0.002152267],"category_scores_gemma":[0.0003687209,0.0002645612,0.001688506,0.000429544,0.0002988322,0.000121936,0.0001287093,0.000438681,0.0008109776],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002738935,"about_ca_system_score_gemma":0.0007184253,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002070412,"about_ca_topic_score_gemma":5.461952e-7,"domain_scores_codex":[0.9969248,0.0004465422,0.001038314,0.000346414,0.0007980315,0.0004459634],"domain_scores_gemma":[0.997118,0.000429875,0.0005113163,0.001648483,0.000108001,0.0001843351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007393376,0.0003881625,0.00001222642,0.01370242,0.000822345,0.000009290606,0.00003253887,0.000002229336,2.614111e-8,0.0002215169,0.01571181,0.9690235],"study_design_scores_gemma":[0.00028292,0.0001505909,0.0005397461,0.03998787,0.001327406,0.00001896809,0.00001886888,0.00001280809,0.000001875793,0.0003216129,0.9570845,0.0002527818],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001802508,0.9957938,0.000001110731,0.0005592108,0.00009325472,0.001373161,0.0001568806,0.00005285689,0.001789455],"genre_scores_gemma":[0.000478532,0.9937458,0.000004220625,0.0009573628,0.00003225577,0.0001041951,0.0001314337,0.00009079747,0.004455396],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9687707,"threshold_uncertainty_score":0.9999807,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1630638098284874,"score_gpt":0.409752862170552,"score_spread":0.2466890523420646,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}